Drugs / \[Al18F\]PSMA137
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04693169 | Jan 2021 → Jun 2024 | prostate cancer | Peking University Cancer Hospital & Institute | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | \[Al18F\]PSMA137 | “\[Al18F\]PSMA137 is a novel PSMA targeted tracer labeled with 18F.” NCT04693169 ↗ |
| Modality | Diagnostic / imaging agent | “\[Al18F\]PSMA137 is a novel PSMA targeted tracer labeled with 18F.” NCT04693169 ↗ |